𝔖 Bobbio Scriptorium

✦ LIBER ✦

Treatment options in relapsed or refractory Hodgkin disease patients: the mini-BEAM regimen does exist too

✍ Scribed by Miguel A. Canales; Alejandro Martin; Dolores Caballero; Fernando Hernandez-Navarro

Book ID: 108673903
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 437 KB
Volume: 134
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2006.06238.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bumeltt (Busulphan, Melphalan, and Thiot

Bumeltt (Busulphan, Melphalan, and Thiotepa) as a Preparative Regimen Prior to Autologous Stem Cell Transplantation in Patients With Relapsed/Refractory Hodgkin'S Disease Does Not Offer Any Advantage Over More Standard Regimens Like Beam or BEAC

✍ S. Ganguly; V. Jain; C.L. Divine; O. Ajitawi; S. Abhyankar; J.P. McGuirk 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Addition of Rituximab to Either BEAC or

Addition of Rituximab to Either BEAC or BEAM in the Preparative Regimen Prior to Autologous Stem Cell Transplantation in Patients With Relapsed B-Cell Non-Hodgkin Lymphoma Does Not Add a Survival Benefit: A Single Center Experience

✍ C.B. Williams; A. Loknath-Kumar; C.L. Divine; O.A. Aljitawi; S. Abhyankar; J.P. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB